RS20060435A - Compostions comprising glycosaminoglycan and nonsteroidal anti-inflammatory drug - Google Patents

Compostions comprising glycosaminoglycan and nonsteroidal anti-inflammatory drug

Info

Publication number
RS20060435A
RS20060435A RSP-2006/0435A RSP20060435A RS20060435A RS 20060435 A RS20060435 A RS 20060435A RS P20060435 A RSP20060435 A RS P20060435A RS 20060435 A RS20060435 A RS 20060435A
Authority
RS
Serbia
Prior art keywords
inflammatory drug
nonsteroidal anti
salts
glycosaminoglycan
compostions
Prior art date
Application number
RSP-2006/0435A
Other languages
English (en)
Inventor
Rajesh JAIN
Kour Chand JINDAL
Sukhjeet Singh
Original Assignee
Panacea Biotec Ltd.,
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Panacea Biotec Ltd., filed Critical Panacea Biotec Ltd.,
Publication of RS20060435A publication Critical patent/RS20060435A/sr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/18—Sulfonamides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/727—Heparin; Heparan
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/728—Hyaluronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)

Abstract

Opisani su farmaceutski sastavi koji sadrže glikozarninoglikan ili njegove soli, pogodno hondroitin ili njegove soli, još pogodnije hondroitin sulfat, i nesteroidni anti-inflamatomi lek(-ove) ili njegove soli, opciono sa farmaceutski prihvatljivim inertnim puniocima. Sastavi ovog pronalaska obezbeđuju gastro-zaštitni efekat pod uslovima kada se koriste nesteroidni anti-inflamatomi lekovi ili njihove soli, naročito kod sisara. Takođe je obezbeđen postupak za proizvodnju takvih novih sastava i metod za minimiziranje gastrične toksičnosti izazvane nesteroidnim anti-inflamatomim lekovima.
RSP-2006/0435A 2004-01-20 2005-01-19 Compostions comprising glycosaminoglycan and nonsteroidal anti-inflammatory drug RS20060435A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN102DE2004 2004-01-20
PCT/IN2005/000026 WO2005067943A1 (en) 2004-01-20 2005-01-19 Compostions comprising glycosaminoglycan and nonsteroidal anti-inflammatory drug

Publications (1)

Publication Number Publication Date
RS20060435A true RS20060435A (en) 2008-09-29

Family

ID=34779370

Family Applications (1)

Application Number Title Priority Date Filing Date
RSP-2006/0435A RS20060435A (en) 2004-01-20 2005-01-19 Compostions comprising glycosaminoglycan and nonsteroidal anti-inflammatory drug

Country Status (11)

Country Link
US (1) US20080261866A1 (sr)
EP (1) EP1747006B1 (sr)
AP (1) AP2006003831A0 (sr)
AT (1) ATE435021T1 (sr)
AU (1) AU2005205422B2 (sr)
CA (1) CA2553781A1 (sr)
DE (1) DE602005015209D1 (sr)
EA (1) EA200602199A1 (sr)
RS (1) RS20060435A (sr)
WO (1) WO2005067943A1 (sr)
ZA (1) ZA200609585B (sr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL2015957B1 (en) * 2015-12-14 2017-06-29 Scala Pharma B V Compositions and methods for inducing beige or brown fat tissue.
WO2018104950A1 (en) * 2016-12-11 2018-06-14 Seanergy Dermatology Ltd. Compositions comprising sulfated polysaccharides
NL2028476B1 (en) * 2021-06-17 2022-12-27 Logick Energetics B V Pharmaceutical composition for increasing mitochondrial activity and/or improving adiponectin production

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5095037B1 (en) * 1989-12-21 1995-12-19 Nissho Kk Combined anti-inflammatory agent
US5972906A (en) * 1991-07-03 1999-10-26 Hyal Pharmaceutical Corporation Treatment of mucous membrane disease, trauma or condition and for the relief of pain thereof
JPH0987174A (ja) * 1995-09-26 1997-03-31 Kobayashi Pharmaceut Co Ltd 鎮痛性および抗炎症性組成物
US5668119A (en) * 1996-02-22 1997-09-16 Medenica; Rajko D. Topical pharmaceutical containing heparin and method of treatment

Also Published As

Publication number Publication date
US20080261866A1 (en) 2008-10-23
AU2005205422A1 (en) 2005-07-28
CA2553781A1 (en) 2005-07-28
EP1747006A1 (en) 2007-01-31
WO2005067943A1 (en) 2005-07-28
DE602005015209D1 (de) 2009-08-13
ATE435021T1 (de) 2009-07-15
AU2005205422B2 (en) 2008-04-24
EP1747006B1 (en) 2009-07-01
ZA200609585B (en) 2008-02-27
EA200602199A1 (ru) 2007-04-27
AP2006003831A0 (en) 2006-12-31

Similar Documents

Publication Publication Date Title
WO2007089745A3 (en) Novel compounds with high therapeutic index
BRPI0520669A2 (pt) dosagem farmacêutica que reduz o efeito do alimento encontrado para administração de atorvastatina
CL2011000124A1 (es) Compuestos derivados de 3-aril-4-heterociclil-pirazoles, inhibidores de proteina quinasa b-raf; metodo de inhibicion in vitro de la proteina quinasa b-raf; composicion farmaceutica; producto de combinacion farmaceutica; y su uso para el tratamiento del cancer.
UA92907C2 (uk) Похідні тетрагідроіндазолону
MXPA05010899A (es) Derivados de 2-aminopirimidina y su uso medico.
NO2013017I1 (no) (a)dekstrometorfan eller et farmasøytisk akseptabelt salt, en forløper eller derivat, for eksempel ekstrometorfanhydrobromid og spesielt dekstrometorfanhydrobromid monohydrat; og (b) quinidin eller etfarmasøytisk akseptabelt salt, en forløper eller derivat derav, for eksempel quinidin og spesielt quinidinsulfat dihydrat
WO2005069933A3 (en) Methods of treating an inflammatory-related disease
EA200900155A1 (ru) Модуляторы фармакокинетических свойств лекарственных средств
EA200900264A1 (ru) Композиции флибансерина и способ их приготовления
TW200833693A (en) Substituted pyrazolo-quinazoline derivatives, process for their preparation and their use as kinase inhibitors
MY147393A (en) Administration of dipeptidyl peptidase inhibitors
TW200714590A (en) Heterocyclic inhibitors of MEK and methods of use thereof
MY140514A (en) Triazolopyridine derivatives as inhibitors of lipases and phospholipases
MX2011012122A (es) Derivados de tiofeno.
MX2008016134A (es) Derivados de fenol para el tratamiento de enfermedades respiratorias.
WO2007035620A3 (en) Carbazole derivatives
WO2006138608A3 (en) Pharmaceutical compositions and use thereof
ECSP055844A (es) Nuevos compuestos triciclicos
BR0210139A (pt) Composições farmacêuticas
TW200603787A (en) Topical preparations containing ambroxol
ATE386725T1 (de) Heterocyclylverbindungen
TNSN07263A1 (en) Substituted 4-phenyl tetrahydroisoquinolines, methods for producing them, their use as drug, and drug containing them
ATE443722T1 (de) Peptide und peptidderivate, ihre herstellung sowie ihre verwendung zur herstellung einer therapeutisch und/oder prophylaktisch wirksamen pharmazeutischen zusammensetzung
WO2008026048A3 (en) Stable injectable pharmaceutical compositions of docetaxel
HUP0300709A2 (hu) Pemetrexedet monotioglikollal, L-ciszteinnel vagy tioglikolsavval együtt tartalmazó gyógyászati készítmény